Read More

Walgreens in the Crosshairs: FDA Warnings Lead to Consumer Lawsuit Over Risky Eye Drops

Walgreens Boots Alliance Inc (NASDAQ: WBA) is in hot water as it grapples with a proposed class action lawsuit in Florida federal court alleging that the pharmacy retailer mislabeled eyedrops designed to treat pink eye (conjunctivitis), misleading consumers into believing the product was safe and effect